Transfer for primary angioplasty in elderly patients with acute myocardial infarction

References

• Jacquemin L, Danchin N, Suty-Selton C, Beurrier D, Grentzinger A, Juilliere Y, et al. Myocardial infarction in patients over 75 years of age. Hospital characteristics and long-term follow-up. Presse Med. 1996; 25: 1536–40
   PubMedGoogle Scholar
• Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2005; 149: 67–73
   PubMed Web of Science ®Google Scholar
• DeGeare VS, Stone GW, Grines L, Brodie BR, Cox DA, Garcia E, et al. Angiographic and clinical characteristics associated with increased in- hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). Am J Cardiol. 2000; 86: 30–4
   PubMed Web of Science ®Google Scholar
• Kirchgatterer A, Weber T, Auer J, Mayr H, Maurer E, Punzengruber C, et al. Coronary angiography in patients over 80 years of age: indications, results, consequences. Acta Med Austriaca 2000; 27: 78–82
   PubMedGoogle Scholar
• Mehta RH, Rathore SS, Radford MJ, Wang Y, Wang Y, Krumholz HM. Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol. 2001; 38: 736–41
   PubMed Web of Science ®Google Scholar
• Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994; 90: 2103–14
   PubMedGoogle Scholar
• Rathore SS, Mehta RH, Wang Y, Radford MJ, Krumholz HM. Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med. 2003; 114: 307–15
   PubMedGoogle Scholar
• Brass LM, Lichtman JH, Wang Y, Gurwitz JH, Radford MJ, Krumholz HM. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. Stroke 2000; 31: 1802–11
   PubMedGoogle Scholar
• de Boer MJ, Ottervanger JP, van't Hof AW, Hoorntje JC, Suryapranata H, Zijlstra F. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 2002; 39: 1723–8
   PubMed Web of Science ®Google Scholar
• Berger AK, Schulman KA, Gersh BJ, Pirzada S, Breall JA, Johnson AE, et al. Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA 1999; 282: 341–8
   PubMedGoogle Scholar
• Zahn R, Schiele R, Schneider S, Gitt AK, Wienbergen H, Seidl K, et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry. J Am Coll Cardiol. 2001; 37: 1827–35
   PubMed Web of Science ®Google Scholar
• Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004; 44: E1–E211
   PubMedGoogle Scholar
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Lancet 1994;343:311–22.
   PubMedGoogle Scholar
• Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992; 268: 1417–22
   PubMed Web of Science ®Google Scholar
• Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13–20
   PubMed Web of Science ®Google Scholar
• Grines Cindy. SENIOR PAMI. A prospective randomized trial of primary angioplasty and thrombolytic therapy in elderly patients with acute myocardial infarction. Presented at TCT; October 16–21, 2005; Washington, DC.
   Google Scholar
• Halon DA, Adawi S, Dobrecky-Mery I, Lewis BS. Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients. J Am Coll Cardiol. 2004; 43: 346–52
   PubMedGoogle Scholar
• Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2002; 23: 1177–89
   PubMed Web of Science ®Google Scholar
• White HD. Thrombolytic therapy in the elderly. Lancet 2000; 356: 2028–30
   PubMed Web of Science ®Google Scholar
• Webb JG, Lowe AM, Sanborn TA, White HD, Sleeper LA, Carere RG, et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol. 2003; 42: 1380–6
   PubMed Web of Science ®Google Scholar
• Dzavik V, Sleeper LA, Cocke TP, Moscucci M, Saucedo J, Hosat S, et al. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J. 2003; 24: 828–37
   PubMedGoogle Scholar
• Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 2003; 108: 1809–14
   PubMed Web of Science ®Google Scholar
• Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J. 2000; 21: 823–31
   PubMed Web of Science ®Google Scholar
• Zijlstra F. Angioplasty vs thrombolysis for acute myocardial infarction: a quantitative overview of the effects of interhospital transportation. Eur Heart J. 2003; 24: 21–3
   PubMedGoogle Scholar
• Guagliumi G, Stone GW, Cox DA, Stuckey T, Tcheng JE, Turco M, et al. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: Results from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. Circulation 2004; 110: 1598–604
   PubMed Web of Science ®Google Scholar
• Tcheng JE, Kandzari DE, Grines CL, Cox DA, Effron MB, Garcia E, et al. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. Circulation 2003; 108: 1316–23
   PubMed Web of Science ®Google Scholar
• De Luca G, Suryapranata H, Ottervanger JP, Van't Hof AW, Hoorntje JC, Dambrink JH, et al. Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Int J Cardiol. 2007; 119(3)306–9
   PubMedGoogle Scholar